N-((6-(4-chlorophenyl)imidazo[2,1-b]thiazol-5-yl)methyl)-2-(3,4-dichlorophenyl)ethan-1-amine

ID: ALA4527619

PubChem CID: 142505420

Max Phase: Preclinical

Molecular Formula: C20H16Cl3N3S

Molecular Weight: 436.80

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Clc1ccc(-c2nc3sccn3c2CNCCc2ccc(Cl)c(Cl)c2)cc1

Standard InChI:  InChI=1S/C20H16Cl3N3S/c21-15-4-2-14(3-5-15)19-18(26-9-10-27-20(26)25-19)12-24-8-7-13-1-6-16(22)17(23)11-13/h1-6,9-11,24H,7-8,12H2

Standard InChI Key:  PEMODJCBCAKYMD-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
    5.2785  -15.1288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2420  -13.8058    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7827  -14.4807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0281  -14.0381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0485  -14.8552    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8319  -15.0883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2957  -14.4153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7989  -13.7663    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.9687  -14.5051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5412  -13.8073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7251  -13.8296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3355  -14.5489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7680  -15.2473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5827  -15.2215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5187  -14.5727    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.0462  -15.9123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6086  -16.5052    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3764  -17.2887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9388  -17.8816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7065  -18.6650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9107  -18.8539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6784  -19.6365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2410  -20.2303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0392  -20.0362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2678  -19.2538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0098  -21.0141    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.8836  -19.8268    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0
  4  2  2  0
  2  3  1  0
  3  1  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  4  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  3  9  1  0
 12 15  1  0
  1 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 23 26  1  0
 22 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4527619

    ---

Associated Targets(Human)

NR1I3 Tchem Nuclear receptor subfamily 1 group I member 3 (655 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR1I2 Tchem Pregnane X receptor (6667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 436.80Molecular Weight (Monoisotopic): 435.0131AlogP: 6.36#Rotatable Bonds: 6
Polar Surface Area: 29.33Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.43CX LogP: 6.13CX LogD: 4.12
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.36Np Likeness Score: -1.82

References

1. Liang D, Li L, Lynch C, Mackowiak B, Hedrich WD, Ai Y, Yin Y, Heyward S, Xia M, Wang H, Xue F..  (2019)  Human constitutive androstane receptor agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapies.,  179  [PMID:31247375] [10.1016/j.ejmech.2019.06.031]

Source